Friederike Oltmanns

Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization

K. Überla, A. Ensser, C. Thirion, 2021, Nature Communications.

Protective mucosal immunity against SARS-CoV-2 after heterologous systemic RNA-mucosal adenoviral vector immunization

K. Überla, A. Ensser, C. Thirion, 2021, bioRxiv.

Influence of AAV vector tropism on long-term expression and Fc-γ receptor binding of an antibody targeting SARS-CoV-2

V. Temchura, Kaveh Roshanbinfar, Leila Issmail, 2024, Communications biology.

Evaluation of adenoviral vector Ad19a encoding RSV-F as novel vaccine against respiratory syncytial virus

D. Lapuente, Jana Fuchs, C. Maier, 2024, NPJ vaccines.